Alembic debuts generic Intuniv
Guanfacine Extended-Release tablets are indicated for the treatment of ADHD as monotherapy and as adjunctive therapy.
Alembic is launching Guanfacine Extended-Release tablets in dosage strengths of 1 mg, 2 mg, 3 mg and 4 mg. The product is the generic of Takeda’s Intuniv Extended-Release tablets.
Guanfacine Extended-Release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder as monotherapy and as adjunctive therapy.
[Read more: Alembic obtains FDA nod for 2 generics]
Alembic will offer its generic product in 100-count bottles.